• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Traditional Chinese Medicine treatment of COVID-19.中医药治疗 COVID-19。
Complement Ther Clin Pract. 2020 May;39:101165. doi: 10.1016/j.ctcp.2020.101165. Epub 2020 Apr 1.
2
Traditional Chinese herbal medicine for treating novel coronavirus (COVID-19) pneumonia: protocol for a systematic review and meta-analysis.中药治疗新型冠状病毒（COVID-19）肺炎：系统评价和荟萃分析的方案。
Syst Rev. 2020 Apr 8;9(1):75. doi: 10.1186/s13643-020-01343-4.
3
Clinical practice guidelines and experts' consensuses of traditional Chinese herbal medicine for novel coronavirus (COVID-19): protocol of a systematic review.临床实践指南和传统中药专家共识治疗新型冠状病毒（COVID-19）：系统评价方案。
Syst Rev. 2020 Aug 3;9(1):170. doi: 10.1186/s13643-020-01432-4.
4
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs.中医可否用于预防 2019 年冠状病毒病（COVID-19）？对历史经典、研究证据和当前预防方案的回顾。
Chin J Integr Med. 2020 Apr;26(4):243-250. doi: 10.1007/s11655-020-3192-6. Epub 2020 Feb 17.
5
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.中药治疗 2019 年新型冠状病毒（SARS-CoV-2）感染患者：综述与展望。
Int J Biol Sci. 2020 Mar 15;16(10):1708-1717. doi: 10.7150/ijbs.45538. eCollection 2020.
6
Databases for facilitating mechanistic investigations of traditional Chinese medicines against COVID-19.促进中药抗COVID-19机制研究的数据库
Pharmacol Res. 2020 Sep;159:104989. doi: 10.1016/j.phrs.2020.104989. Epub 2020 Jun 2.
7
Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19).成为忠实捍卫者：中医药抗击 2019 年冠状病毒病（COVID-19）。
Am J Chin Med. 2020;48(4):763-777. doi: 10.1142/S0192415X2050038X. Epub 2020 Apr 29.
8
East meets West in COVID-19 therapeutics.在新冠病毒治疗中，东西方相遇了。
Pharmacol Res. 2020 Sep;159:105008. doi: 10.1016/j.phrs.2020.105008. Epub 2020 Jun 9.
9
The combined therapy of a traditional Chinese medicine formula and Western medicine for a critically ill case infected with COVID-19.中药配方联合西药治疗 COVID-19 危重症病例。
Complement Ther Med. 2020 Aug;52:102473. doi: 10.1016/j.ctim.2020.102473. Epub 2020 Jun 9.
10
[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].[中草药及其活性成分干预人类冠状病毒的研究进展]
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1263-1271. doi: 10.19540/j.cnki.cjcmm.20200219.501.

引用本文的文献

1
Exploration of Specific Fluoroquinolone Interaction with SARS-CoV-2 Main Protease (Mpro) to Battle COVID-19: DFT, Molecular Docking, ADME and Cardiotoxicity Studies.探索氟喹诺酮类药物与 SARS-CoV-2 主蛋白酶（Mpro）的特异性相互作用以对抗 COVID-19：DFT、分子对接、ADME 和心脏毒性研究。
Molecules. 2024 Oct 5;29(19):4721. doi: 10.3390/molecules29194721.
2
A Narrative Overview of Coronavirus Infection: Clinical Signs and Symptoms, Viral Entry and Replication, Treatment Modalities, and Management.冠状病毒感染的叙述性概述：临床体征和症状、病毒进入和复制、治疗方式和管理。
Curr Top Med Chem. 2024;24(21):1883-1916. doi: 10.2174/0115680266296095240529114058.
3
The Role of Traditional Chinese Medicine and Chinese Pharmacopoeia in the Evaluation and Treatment of COVID-19.中医药和《中国药典》在评估和治疗 COVID-19 中的作用。
Curr Pharm Des. 2024;30(14):1060-1074. doi: 10.2174/0113816128217263240220060252.
4
anti-viral assessment of phytoconstituents in a traditional (Siddha Medicine) polyherbal formulation - Targeting Mpro and pan-coronavirus post-fusion Spike protein.一种传统（悉达医学）多草药配方中植物成分的抗病毒评估——以M蛋白酶和泛冠状病毒融合后刺突蛋白为靶点
J Tradit Complement Med. 2023 Jul 13;14(1):55-69. doi: 10.1016/j.jtcme.2023.07.004. eCollection 2024 Jan.
5
Nigella sativa and its chemical constituents: pre-clinical and clinical evidence for their potential anti-SARS-CoV-2 effects.黑种草及其化学成分：其潜在抗 SARS-CoV-2 作用的临床前和临床证据。
Inflammopharmacology. 2024 Feb;32(1):273-285. doi: 10.1007/s10787-023-01385-9. Epub 2023 Nov 15.
6
Temporal and Emotional Variations in People's Perceptions of Mass Epidemic Infectious Disease After the COVID-19 Pandemic Using Influenza A as an Example: Topic Modeling and Sentiment Analysis Based on Weibo Data.基于微博数据的主题建模和情感分析：以甲型流感为例探讨 COVID-19 大流行后人们对大规模传染病的时间和情感变化
J Med Internet Res. 2023 Nov 2;25:e49300. doi: 10.2196/49300.
7
Assessing the design of China's complex health system - Concerns on equity and efficiency.评估中国复杂卫生系统的设计——对公平与效率的关注
Health Policy Open. 2020 Nov 21;1:100021. doi: 10.1016/j.hpopen.2020.100021. eCollection 2020 Dec.
8
Emergency Protective Measures and Strategies of COVID-19: From Lifestyle to Traditional Chinese Medicine.新型冠状病毒肺炎的应急防护措施与策略：从生活方式到中医药
Clin Complement Med Pharmacol. 2023 Sep;3(3):100089. doi: 10.1016/j.ccmp.2023.100089. Epub 2023 Apr 6.
9
An overview on medicinal plants used for combating coronavirus: Current potentials and challenges.用于对抗冠状病毒的药用植物综述：当前的潜力与挑战
J Agric Food Res. 2023 Sep;13:100632. doi: 10.1016/j.jafr.2023.100632. Epub 2023 May 20.
10
Schisandrin B inhibits tumor progression of hepatocellular carcinoma by targeting the RhoA/ROCK1 pathway.五味子乙素通过靶向RhoA/ROCK1通路抑制肝细胞癌的肿瘤进展。
J Gastrointest Oncol. 2023 Apr 29;14(2):533-543. doi: 10.21037/jgo-23-87.

本文引用的文献

1
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
2
Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis.用于严重急性呼吸综合征的中药：系统评价与荟萃分析。
J Altern Complement Med. 2004 Dec;10(6):1041-51. doi: 10.1089/acm.2004.10.1041.
3
Hygiene and preventive medicine in ancient China.中国古代的卫生与预防医学。
J Hist Med Allied Sci. 1962 Oct;17:429-78. doi: 10.1093/jhmas/xvii.4.429.

中医药治疗 COVID-19。

Traditional Chinese Medicine treatment of COVID-19.

机构信息

Sichuan Integrative Medicine Hospital, Chengdu, Sichuan Province, China.

Sichuan Integrative Medicine Hospital, Chengdu, Sichuan Province, China.

出版信息

Complement Ther Clin Pract. 2020 May;39:101165. doi: 10.1016/j.ctcp.2020.101165. Epub 2020 Apr 1.

DOI:10.1016/j.ctcp.2020.101165
PMID:32379692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7118627/
Abstract

A new kind of Pneumonia caused by new corona virus has been widespread in China since winter of 2019. No effective treatment for this disease was verified, so the morbidity and mortality rate were supposed higher than flu. The Traditional Chinese Medicine is widely used in clinical practice in China, but many other countries of the world to deal with diseases that remain clinically challenging.

摘要

自 2019 年冬季以来，一种由新型冠状病毒引起的新型肺炎在中国广泛传播。这种疾病没有经过有效的治疗验证，因此发病率和死亡率可能高于流感。中医药在中国临床实践中得到广泛应用，但世界上许多其他国家在应对具有临床挑战性的疾病时仍在观望。